US2009181420A1PendingUtilityA1

Inhibiting Smad signaling promotes neuron regeneration

Assignee: UNIV DUKEPriority: Aug 6, 2006Filed: Mar 13, 2009Published: Jul 16, 2009
Est. expiryAug 6, 2026(~0 yrs left)· nominal 20-yr term from priority
C07K 14/4702A61P 25/28A61K 48/005
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Regeneration of a lesioned CNS axon of a mature neuron, determined to be subject to regeneration inhibition by Smad2/3 signaling, is promoted by contacting the neuron with an inhibitor of Smad2/3 signaling sufficient to promote regeneration of the axon.

Claims

exact text as granted — not AI-modified
1 . A method of promoting neurite outgrowth, the method comprising the steps of:
 (a) contacting the neuron in situ with an inhibitor of Smad2/3 signaling; and   (b) detecting a resultant promotion of neurite outgrowth of the neuron, wherein the neuron is an adult dorsal root ganglion (DRG) cell, and the inhibitor is selected from the group consisting of 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide (SB-431542), -2-(5-benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride (SB-505124) and 4-{4-[3-(Pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H-pyran-4-yl)benzamide (GW788388).   
   
   
       2 - 13 . (canceled) 
   
   
       14 . The method of  claim 1  wherein the inhibitor is 2-(5-benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride (SB-505124). 
   
   
       15 . A method of promoting neurite outgrowth, the method comprising the steps of:
 (a) contacting the neuron in situ with an inhibitor of Smad2/3 signaling;   (b) isolating and culturing the neuron in vitro; and   (c) detecting a resultant promotion of neurite outgrowth of the neuron in vitro, wherein the neuron is an adult dorsal root ganglion (DRG) cell and the inhibitor is selected from the group consisting of 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide (SB-431542), 2-(5-benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride (SB-505124) and 4-{4-[3-(Pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H-pyran-4-yl)benzamide (GW788388).

Join the waitlist — get patent alerts

Track US2009181420A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.